Last reviewed · How we verify

NCT06826495

Thiol Disulfide Balance and Oxidative Stress Change in Endometrial Polyp Patients

Completed Last updated 14 February 2025
What this trial tests

trial in Endometrial Polyp in 54 participants. Completed in 5 January 2022.

Timeline
2 January 2021
Primary endpoint
3 January 2022
5 January 2022

Quick facts

Lead sponsorMardin Artuklu University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment54
Start date2 January 2021
Primary completion3 January 2022
Estimated completion5 January 2022
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Mardin Artuklu University

Who can join

Adults 20 to 48, female only, with Endometrial Polyp or Oxidative Stress. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Changes in Thiol Disulfide Balance and Oxidative Stress Mechanisms in Patients with Endometrial Polyps

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endometrial Polyp

Currently open trials in the same condition.

Other Mardin Artuklu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06826495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing